Published in Br Med J on January 21, 1978
Arterial thrombosis and accelerated atheroma in a member of a family with familial antithrombin III deficiency. Postgrad Med J (1982) 0.81
Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas. Br J Pharmacol (1980) 0.80
Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus. J Clin Pathol (1983) 0.77
Risk associated with heparin withdrawal in ischaemic cerebrovascular disease. J Neurol Neurosurg Psychiatry (1989) 0.77
Mechanisms of deep vein thrombosis: a review. J R Soc Med (1979) 0.76
Thrombosis after venography in familial antithrombin II deficiency. Br Med J (Clin Res Ed) (1981) 0.76
Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds. J Med Genet (1988) 0.75
Familial venous thrombosis. Postgrad Med J (1983) 0.75
Quite a backup: pericardial varices in a patient with hereditary antithrombin deficiency. Quant Imaging Med Surg (2013) 0.75
The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem (1973) 4.24
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh (1965) 3.80
Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis. Lancet (1976) 2.77
Anticoagulant action of heparin. Nature (1973) 2.26
Familial thrombosis due to antithrombin 3 deficiency. Blood (1974) 1.73
Antithrombin 3, antifactor Xa and heparin. Br J Haematol (1970) 1.31
The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin. J Biol Chem (1966) 1.28
Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haematol (1970) 1.22
Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function. Am J Med (1976) 1.20
Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Thromb Diath Haemorrh (1974) 1.10
Antithrombin-3 deficiency in a Dutch family. J Clin Pathol (1973) 1.06
Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor. J Biol Chem (1971) 1.06
Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity. Ann Surg (1975) 1.04
Oral contraceptives and low antithrombin-3 activity. Lancet (1970) 1.04
Assay of progressive antithrombin in plasma. Thromb Diath Haemorrh (1970) 1.02
Biological properties of the naturally occurring plasma inhibitor to activated factor X. J Biol Chem (1971) 0.99
Hereditary antithrombin III deficiency and thromboembolic disease. Am J Hematol (1976) 0.97
Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiency. Scand J Haematol (1977) 0.90
Familial thrombosis due to antithrombin III deficiency in a Greek family. Acta Haematol (1977) 0.82
Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency. S Afr Med J (1976) 0.81
Proceedings: Inherited antithrombin III deficiency and thrombo-embolism. Thromb Diath Haemorrh (1975) 0.81
Proceedings: The significance of the chronic anticoagulant treatment in recurrent thromboembolie caused by hereditary antithrombin III deficiency. Thromb Diath Haemorrh (1975) 0.80
[Recurrent thromboembolism in children caused by hereditary antithrombin III deficiency]. Folia Haematol Int Mag Klin Morphol Blutforsch (1975) 0.80
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1968) 4.57
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
The children's depression inventory: a systematic evaluation of psychometric properties. J Consult Clin Psychol (1984) 3.41
Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev (1999) 3.41
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol (1993) 3.14
Crude-oil biodegradation via methanogenesis in subsurface petroleum reservoirs. Nature (2007) 3.06
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med (1992) 3.05
The expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in neurochemically defined axonal populations in the rat spinal cord with emphasis on the dorsal horn. Eur J Neurosci (2003) 2.72
D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med (1975) 2.56
Studies on the migration inhibitory factor associated with delayed-type hypersensitivity: cytodynamics and specificity. Transplantation (1967) 2.52
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Improving public health information: a data quality intervention in KwaZulu-Natal, South Africa. Bull World Health Organ (2011) 2.37
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Changing seasonality of birth--a possible environmental effect. J Epidemiol Community Health (1993) 2.09
Changing incidence of Achilles tendon rupture in Scotland: a 15-year study. Clin J Sport Med (1999) 2.07
Migration inhibitory factor associated with delayed-type hypersensitivity. Fed Proc (1990) 2.02
Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J (1969) 1.92
Specific suppression of tumor growth by isolated peritoneal macrophages from immunized mice. J Immunol (1965) 1.90
Modeling the motion of the internal tongue from tagged cine-MRI images. J Acoust Soc Am (2001) 1.78
Reconstitution of the [4Fe-4S] cluster in FNR and demonstration of the aerobic-anaerobic transcription switch in vitro. Biochem J (1996) 1.78
A method to reconstruct myocardial sarcomere lengths and orientations at transmural sites in beating canine hearts. Am J Physiol (1992) 1.71
Epidemiological study of respiratory disease in workers exposed to polyvinylchloride dust. Thorax (1980) 1.69
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Fibrinolytic enzyme system and pregnancy. Br Med J (1969) 1.63
Prostatic calculi: a review. Prostate (1985) 1.62
Isolation and cultivation in vitro of macrophages from various sources in the mouse. Am J Pathol (1966) 1.59
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol (2000) 1.54
Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther (1999) 1.52
Fat necrosis and inflammatory pseudotumor due to endoscopic tattooing of the colon with india ink. Gastrointest Endosc (1991) 1.50
Venous thrombosis following strokes. Lancet (1972) 1.46
Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J (1971) 1.39
Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol (1988) 1.38
What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer (1996) 1.37
Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med (1997) 1.37
Sulfite:Cytochrome c oxidoreductase from Thiobacillus novellus. Purification, characterization, and molecular biology of a heterodimeric member of the sulfite oxidase family. J Biol Chem (2000) 1.31
NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. J Immunol (2001) 1.28
Modeling tongue surface contours from Cine-MRI images. J Speech Lang Hear Res (2001) 1.27
Relation of the migration inhibitory factor (MIF) to delayed-type hypersensitivity reactions. Ann N Y Acad Sci (1970) 1.26
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling. Development (2003) 1.26
Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab (2011) 1.25
Divalent metal binding properties of the methionyl aminopeptidase from Escherichia coli. Biochemistry (2000) 1.23
Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J (1970) 1.21
Changes in antihemophilic factor (AHF, factor 8) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography. J Lab Clin Med (1972) 1.21
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration. Proc Natl Acad Sci U S A (1969) 1.17
Self-administration of cocaine analogs by rats. Psychopharmacology (Berl) (1999) 1.17
Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Blood Coagul Fibrinolysis (1995) 1.16
Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens. Cancer (1983) 1.16
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
P boutons in lamina IX of the rodent spinal cord express high levels of glutamic acid decarboxylase-65 and originate from cells in deep medial dorsal horn. Proc Natl Acad Sci U S A (2005) 1.14
The effect on dipyridamole on platelet aggregation and adhesiveness. Scott Med J (1968) 1.14
Clinical and psychological outcome from a randomized controlled trial of patient-initiated direct-access hospital follow-up for rheumatoid arthritis extended to 4 years. Rheumatology (Oxford) (2003) 1.13
Streptokinase in iliofemoral venous thrombosis. Br J Surg (1969) 1.13
Xanthogranulomatous pyelonephritis: detailed analysis of 29 cases and a brief discussion of atypical presentations. J Urol (1981) 1.13
Diagnosis of deep vein thrombosis using autologous indium-III-labelled platelets. Br Med J (Clin Res Ed) (1981) 1.12
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. J Clin Pathol (1984) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. J Immunol (1984) 1.08
Development of a trehalose 6,6'-dimycolate model which explains cord formation by Mycobacterium tuberculosis. Infect Immun (1993) 1.08
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Plasminogen-activator-producing tumour. Br Med J (1969) 1.07
Disseminated intravascular coagulation: a review. J Clin Pathol (1978) 1.07
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
Confirmation of quantitative trait loci for ethanol sensitivity in long-sleep and short-sleep mice. Genome Res (1997) 1.05
Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. J Womens Health (Larchmt) (2003) 1.05
In vivo determination of the molecular composition of artery wall by intravascular Raman spectroscopy. Anal Chem (2000) 1.05
Proteins of the fibrinolytic system in human thrombi. Thromb Haemost (1996) 1.04
Exposure to vinyl chloride and angiosarcoma of the liver: a report of the register of cases. Br J Ind Med (1985) 1.04
Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy. Arch Neurol (1998) 1.03
Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children. Diabetologia (2010) 1.03
Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol (1995) 1.02
The temporal stability and co-morbidity of prolonged fatigue: a longitudinal study in primary care. Psychol Med (1999) 1.02
Indium-111 labelled platelets in diagnosis of leg-vein thrombosis: preliminary findings. Br Med J (1980) 1.02
Occupationally related angiosarcoma of the liver in the United Kingdom 1972-1994. Gut (1996) 1.02
Outcome in colorectal adenocarcinoma: two seven-year studies of a population. BMJ (1993) 1.02
Hemophilia A and von Willebrand's disease: the relationship examined. Ann N Y Acad Sci (1975) 1.01
Pneumoperitoneum as a risk factor for endobronchial intubation during laparoscopic gynecologic surgery. Anesth Analg (1998) 1.01
Experience with minimal complications in implanted catheters in children. Am J Pediatr Hematol Oncol (1989) 1.00
Individualisation of oral anticoagulant therapy. Drugs (1979) 1.00
Evidence favoring molybdenum-carbon bond formation in xanthine oxidase action: 17Q- and 13C-ENDOR and kinetic studies. Biochemistry (1996) 1.00
Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol (1991) 0.99
Bone mineral content in Polynesian and white New Zealand women. Br Med J (Clin Res Ed) (1986) 0.99
Macrophages and delayed-type hypersensitivity. Semin Hematol (1970) 0.98
Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J (1972) 0.98
Renal complications in haemophilia and Christmas disease. Q J Med (1971) 0.98